HSP90 inhibitor progress
|Posted by Julie Royster (juliecontent) on Mar 12 2007|
|GIST In the News >>|
Recent news stories review the rationale of inhibiting Heat Shock Protein 90 (HSP90) in gastrointestinal stromal tumor and other cancers. There are a number of HSP90 inhibitors in current clinical trials for GIST (see our page under Emerging Treatments). Acess the news stories below for summaries of progress in this area.
Last changed: Mar 12 2007 at 9:34 AMBack